Eurocine Vaccines´ CEO Hans Arwidsson will present (in Swedish) at Aktieportföljen Live and share recent progress on the chlamydia vaccine development and how the company works to build the portfolio of product candidates. The presentation starts at 17.10 CET and can be viewed via this link: https://www.borskollen.se/nyheter/27/aktieportfoljen-live-25-8-finns-nasta-heta-aktiecase-bland-dessa-18-innovativa-bolag